12/03/2024 3:45 PM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 11:24 AM | BARCLAYS PLC (Filed by) Kezar Life Sciences (Subject)
| Form SCHEDULE 13G/A | |
10/29/2024 4:05 PM | Kezar Life Sciences (Filer)
| Form 8-A12B/A | |
10/28/2024 3:06 PM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 8:22 AM | Kezar Life Sciences (Filer)
| Form 8-A12B | |
10/17/2024 7:47 AM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 7:42 AM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/08/2024 3:20 PM | Kezar Life Sciences (Subject) TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
10/04/2024 4:05 PM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:36 AM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 4:41 PM | Kezar Life Sciences (Issuer) Schiller Mark C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) Kezar Life Sciences (Subject)
| Form SC 13G/A | |
06/04/2024 3:30 PM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | Kezar Life Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 3:12 PM | Kezar Life Sciences (Filer)
| Form ARS | |
04/16/2024 3:18 PM | Kezar Life Sciences (Filer)
| Form PRE 14A | |
03/14/2024 3:33 PM | Kezar Life Sciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024 5:44 PM | BARCLAYS PLC (Filed by) Kezar Life Sciences (Subject)
| Form SC 13G | |
02/14/2024 5:47 PM | Kezar Life Sciences (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 5:50 AM | Avidity Partners Management LP (Filed by) Kezar Life Sciences (Subject)
| Form SC 13G/A | |
02/13/2024 10:55 AM | Kezar Life Sciences (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 8:50 AM | Kezar Life Sciences (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
01/29/2024 2:26 PM | Kezar Life Sciences (Subject)
| Form SC 13G/A | |
01/23/2024 8:15 AM | Kezar Life Sciences (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024 3:04 PM | Kezar Life Sciences (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/17/2024 4:09 PM | Kezar Life Sciences (Issuer) Schiller Mark C. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/09/2024 3:57 PM | Kezar Life Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:36 AM | Kezar Life Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |